Fragmin

Fragmin (Dalteparin Sodium) is a low-molecular-weight heparin used for preventing and treating blood clots. This subcutaneous injection is commonly prescribed for conditions requiring anticoagulation therapy.

Fragmin is primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism. It may also be used in patients undergoing certain medical procedures to reduce the risk of blood clots. Fragmin is often prescribed for its anticoagulant properties, helping to thin the blood and improve circulation.

Common effects of Fragmin may include bruising, bleeding, and irritation at the injection site. Some users may experience allergic reactions or changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Fragmin should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed dosage and administration guidelines to minimize the risk of bleeding complications. Patients with a history of bleeding disorders or allergies should inform their healthcare provider before use.

Fragmin may interact with other anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain medications that affect blood clotting. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.